What type of medication is Aklief (trifarotene)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Aklief (Trifarotene): A Topical Retinoid for Acne Treatment

Aklief (trifarotene) is a first-in-class, fourth-generation topical retinoid that selectively targets retinoic acid receptor-gamma (RAR-γ) for the treatment of acne vulgaris. 1, 2

Classification and Mechanism of Action

  • Trifarotene is classified as a terphenyl acid derivative retinoid with selective activity for RAR-γ, which is the most common retinoic acid receptor isoform in the skin 3, 2
  • As a retinoid, trifarotene works through an "antikeratinizing" effect that normalizes follicular keratinization, reduces hyperkeratosis, and has anti-inflammatory properties 4, 2
  • Trifarotene acts by increasing keratinocyte differentiation and decreasing proliferation, which reduces comedone formation 2
  • The medication also inhibits inflammatory pathways via effects on leukocyte migration, toll-like receptors, and Activator Protein (AP)-1 2

FDA Approval and Formulation

  • Trifarotene received its first global approval in the USA in October 2019 for the topical treatment of acne vulgaris in patients 9 years of age and older 1
  • Aklief Cream contains 0.005% (50 mcg/g) trifarotene, a much lower concentration than other topical retinoids due to its high selectivity for RAR-γ 3, 2
  • The formulation includes inactive ingredients such as allantoin, copolymer of acrylamide and sodium acryloyldimethyltaurate, cyclomethicone, ethanol, medium-chain triglycerides, phenoxyethanol, propylene glycol, and purified water 3

Clinical Applications

  • Trifarotene is indicated for both facial and truncal acne, making it the first topical retinoid with rigorous clinical data supporting efficacy for acne on the trunk 5, 2
  • The American Academy of Dermatology recommends topical retinoids like trifarotene as first-line therapy for acne treatment due to their comedolytic and anti-inflammatory properties 4
  • Trifarotene can be used as monotherapy for mild acne or in combination with benzoyl peroxide for moderate acne 4
  • For severe acne, trifarotene can be part of a combination regimen including oral antibiotics and benzoyl peroxide 4
  • Emerging evidence suggests trifarotene may also improve acne-induced scars (AIS) and acne-induced macular hyperpigmentation (AIH) 6

Advantages Over Other Retinoids

  • Trifarotene is the only topical retinoid specifically approved for both facial and truncal acne treatment 5, 2
  • Its selective targeting of RAR-γ allows for efficacy at a much lower concentration (0.005%) compared to other topical retinoids 3, 2
  • Clinical trials have demonstrated good tolerability with the common retinoid-associated side effects being generally manageable 5, 6

Common Side Effects and Management

  • Like other topical retinoids, trifarotene can cause local skin reactions including erythema, scaling, dryness, stinging/burning, and pruritus 5, 6
  • Photosensitivity may occur, requiring patients to use sunscreen and minimize sun exposure 4
  • To minimize irritation, patients can start with less frequent application (every other day) and gradually increase to daily use as tolerance develops 7
  • Combining trifarotene with moisturizers can help reduce irritation while maintaining efficacy 7, 6

Precautions and Contraindications

  • As with other retinoids, trifarotene should be used with caution during pregnancy 7
  • The medication may cause initial worsening of acne before improvement is seen, typically within the first few weeks of treatment 7
  • Patients should be advised that trifarotene may bleach clothing or bedding 4

Trifarotene represents an important advancement in acne therapy as the first topical retinoid specifically designed and approved for both facial and truncal acne, with a unique selective mechanism of action targeting RAR-γ receptors.

References

Research

Management of Acne Vulgaris With Trifarotene.

Journal of cutaneous medicine and surgery, 2023

Guideline

Treatment Options for Back Acne

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Trifarotene for the Treatment of Facial and Truncal Acne.

The Annals of pharmacotherapy, 2021

Guideline

Tretinoin for Keratosis Pilaris Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.